Skip to content
World of Video Gaming – Lifestyle
Author:
InflaRx N.V.
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 6, 2026
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
May 4, 2026
←
Previous Page
1
2